Transparency data: 2019 voluntary scheme for branded medicines pricing and access operational review minutes: 15 July 2020

Department Of Health

October 3
14:19 2022


The voluntary scheme for branded medicines pricing and access (VPAS) is a non-contractual voluntary agreement between the government (constituted of the Department of Health and Social Care (DHSC), NHS England and the governments of Scotland, Wales and Northern Ireland) and the Association of the British Pharmaceutical Industry (ABPI), the representative body of the UK pharmaceutical industry.

VPAS aims to:

  • improve patient access to medicines by getting the best value and most effective medicines into use more quickly
  • keep the branded medicine bill affordable for theNHSthrough a cap in growth of branded sales
  • support innovation and a successful life sciences industry in theUK

Operational review meetings are held every 6 months.

Published 3 October 2022

Related Articles


  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:

Post my comment

News Calendar

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: